Drug repurposing based on the similarity gene expression signatures to explore for potential indications of quercetin: a case study of multiple sclerosis.

Abstract

Quercetin (QR) is a natural flavonol compound widely distributed in the plant kingdom with extensive pharmacological effects. To find the potential clinical indications of QR, 156 differentially expressed genes (DEGs) regulated by QR were obtained from the Gene Expression Omnibus database, and new potential pharmacological effects and clinical indications of QR were repurposed by integrating compounds with similar gene perturbation signatures and associated-disease signatures to QR based on the Connectivity Map and Coexpedia platforms. The results suggested QR has mainly potential therapeutic effects on multiple sclerosis (MS), osteoarthritis, type 2 diabetes mellitus, and acute leukemia. Then, MS was selected for subsequent animal experiments as a representative potential indication, and it found that QR significantly delays the onset time of classical MS model animal mice and ameliorates the inflammatory infiltration and demyelination in the central nervous system. Combined with network pharmacology technology, the therapeutic mechanism of QR on MS was further demonstrated to be related to the inhibition of the expression of inflammatory cytokines (TNF-α, IL-6, IL-1β, IFN-γ, IL-17A, and IL-2) related to TNF-α/TNFR1 signaling pathway. In conclusion, this study expanded the clinical indications of QR and preliminarily confirmed the therapeutic effect and potential mechanism of QR on MS.

• Authors: Yulong Chen, Mingliang Zhang, Weixia Li, Xiaoyan Wang, Xiaofei Chen, Yali Wu, Hui Zhang, Liuqing Yang, Bing Han, Jinfa Tang
• Journal: Frontiers in chemistry (Front Chem) Vol. 11 Pg. 1250043 ( 2023) ISSN: 2296-2646 [Print] Switzerland
• PMID: 37744058 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 Chen, Zhang, Li, Wang, Chen, Wu, Zhang, Yang, Han and Tang.